Foren & Soziale Netzwerke zur HIMS & HERS Aktie

 

Kursziel: -

Kursziel: -

6/25/25 :: VROCKSTAR :: NYSE:HIMS How I'm trading this for size - i make a lot of moves, as you can tell. but you'll also notice i tend to find positions that i like as i validate the thesis... and go massive - NYSE:HIMS and NASDAQ:TSLA are two names that i'm not new to, but have been wrangling for some time given valuations really haven't been "cheap" per se. there's a good reason for that. - so $hims. i reset book last night, and now after seeing this thing to red on the day after opening to a squeeze nearly >5%... i'm back to wranging. i. want. to. own. this. it's scarce paper. a scarce CEO. scarce growth. and it's hitting right at the heart of the war on pharma, in it's own "novel" way that just makes me excited to root for the success. - valuation is not honestly, expensive - but communication and headlines will drive a lot of price action (as has been the case) now that NVO has unofficially announced that they're losing market share and, frankly, the stock is uninvestable and will ultimately u

6/23/25 :: VROCKSTAR :: NYSE:HIMS Time to re-accumulate - NYSE:NVO are playing dirty and this is a tell and low-key admission that NYSE:HIMS holds all the power - distribution is key... look at NASDAQ:META , NASDAQ:AAPL , $AMZN. he who holds the customer relationship makes the rules - there is no longer a major advantage in developing pharma, the majority of solutions can now roll off patents and/or be compounded *legally* - so what you're seeing here is cartel-like behavior from a slow motion train wreck NYSE:NVO - which i've liked the past - but ultimately the stock will lose to names like NYSE:HIMS (and other pharma too). - so will they get sued? who tf cares. we'll buy more - this is a rule of 40 winner, even if law suit is large, it won't affect the story and growth. and major kudos to Andrew (the rockstar CEO) that put out this tweet. this is a founder-leader you want to put your portfolio behind when the opportunities arise. i'll be looking for oppty in the coming days/weeks to own more o

Kursziel: -

? NYSE:HIMS setting up for its next big move—here's what I'm watching! ? ? Eyeing momentum down to $44-$48, and I'm not mad about it! ? That flip from resistance to support is key for long-term price growth. ? Bull flag breakout could come sooner—stay locked in! Keeping an eye on it all for the next trade entry on this beast! ? What's your take? Are we bouncing or breaking out? Drop your thoughts below! ⬇️

Hims & Hers (HIMS) just gave us a textbook Ichimoku breakout and is holding strong above the cloud after a healthy pullback. Technical Breakdown: Price above Kumo Cloud: Bullish structure intact. Support held at $54.62 – key base above cloud and Tenkan-sen. MACD is curling back after a corrective wave, showing early signs of momentum returning. Risk/Reward: 8.59 – Extremely favorable. Target: $93.58 (60.22% upside) Stop: $51.78 (7.01% downside) Rationale: HIMS continues to ride bullish sentiment in the healthcare and telemedicine sectors. This chart has a clean continuation setup with institutional buy zones likely around $54-$55. Risk is tightly controlled, and upside potential is significant.

Kursziel: -

HIMS has been one of the hottest stocks in the market recently, with a massive run fueled by strong earnings. But now we're seeing the first meaningful pullback — and this could be a golden opportunity: ? Earnings Gap Reversal (Bullish Signal) Despite an earnings gap down, buyers stepped in aggressively, pushing the stock higher. This is a classic earnings gap down reversal — a strong sign of demand. ? First Pullback Opportunity Historically, the first pullback after a major run tends to get bought. I'm watching two key levels for a potential buy: The shaded zone between the 9 EMA and 20 EMA (dynamic support). The 0.38 - 0.50 Fibonacci retracement for added confirmation. ? My Trading Plan: 1️⃣ Initial Entry: Starter position in the shaded EMA zone (9 EMA - 20 EMA). 2️⃣ Confirmation Add: If price bounces off the Fib zone (0.38 - 0.50) with strength. 3️⃣ Stop Loss: Below the 20 EMA for any initial position — keeping risk tight. ? Why This Setup is Compelling: Strong run + earnings reversal shows real

Kursziel: 100.0 €

Bullish Scenario If HIMS continues higher, we may see a shallow pullback first, possibly around 46.75, which lines up with one of my key levels and the uptrend line drawn from late April. A slightly deeper dip into the 10EMA would also be a healthy reset. From there, a move back through last week's high and a continuation up along the uptrend line would confirm strength and keep this breakout intact. If momentum holds, I'm watching for a move toward 65, which sits just below the all-time high. This area could act as resistance, gearing up to establish a new ATH. If we get a new ATH, I'd could see the momentum gain to the upside from the excitement, then an immediate period of digestion, either sideways or a decline as buyers take profits. Neutral Scenario A sideways range around the current zone would be healthy digestion after the recent run. This could look like price holding between the retest levels (roughly 52–56), bouncing in a tight range as momentum resets. In this c

Kursziel: 54.0094 €

NYSE:HIMS is HIMS! 80% Upside Ahead Demolished earnings and I have this name at a fair value of $76 per share based on HIMS 2030 $6.5B Rev. Guidance. Also, H5_L Indicator is about to cross bullish while the Wr% is rising and swinging from green to red! Profit Targets: - $50 - $60 - ATHs! Before EOY! Not financial Advice

Kursziel: 60.0 €

Kursziel: 22.828 €

Bullish A break and hold above the 20EMA would shift momentum back to the upside. Initial resistance would be around 30, where previous price congestion sits. If buyers can push through, next target would be around 35–36, near the declining 50SMA. There is a short-term intraday trendline forming on the hourly chart that could act as a support guide if the stock starts climbing. Bearish A rejection from the downtrend line or failure to hold above the 20EMA could lead to a move lower. Breaking below the 24–25 support area would be a key bearish trigger. If that level fails, the next major downside target would be near 19.5. Neutral Continued sideways chop around the moving averages.

Kursziel: 22.035 €

Kursziel: 39.0 €

Where is NYSE:HIMS going next? Massive upside Watch now to find out! Not financial advice

Bullish about the business, but the chart is really an ugly one.